Kodama F, Greene G L, Salmon S E
Cancer Res. 1985 Jun;45(6):2720-4.
Expression of estrogen receptor (ER) was studied in the ER-positive human breast cancer cell line MCF-7 using immunoperoxidase staining with monoclonal antibodies to ER. Using a soft agar colony assay and liquid culture, effects of growth and the antiestrogen tamoxifen were examined. Heterogeneity in expression of ER was observed between different clones in the agar cultures as well as among cells within the same clone. Clonal expression of ER increased progressively with increasing cell number within a clone. At pharmacological doses, tamoxifen significantly reduced clonal growth but also markedly reduced the expression of ER within clones that grew despite the presence of the antiestrogen. These findings are consistent with the hypothesis that ER-positive colonies arise from ER-negative progenitors and that ER expression occurs along with differentiation of cells within clones. Furthermore, the findings are consistent with tamoxifen exerting its antineoplastic action beyond the level of the tumor stem cell. Such therapy would therefore be capable of suppression but not eradication of breast cancer clonal progenitors.
使用针对雌激素受体(ER)的单克隆抗体通过免疫过氧化物酶染色法,对雌激素受体阳性的人乳腺癌细胞系MCF-7中的ER表达进行了研究。采用软琼脂集落测定法和液体培养法,检测了生长和抗雌激素他莫昔芬的作用。在琼脂培养物中的不同克隆之间以及同一克隆内的细胞之间观察到ER表达的异质性。在一个克隆内,ER的克隆表达随着细胞数量的增加而逐渐增加。在药理学剂量下,他莫昔芬显著降低克隆生长,但也显著降低了尽管存在抗雌激素仍能生长的克隆内ER的表达。这些发现与以下假设一致,即ER阳性集落源自ER阴性祖细胞,并且ER表达与克隆内细胞的分化同时发生。此外,这些发现与他莫昔芬在肿瘤干细胞水平之外发挥其抗肿瘤作用一致。因此,这种疗法能够抑制但不能根除乳腺癌克隆祖细胞。